AI Article Synopsis

  • SLC25A46 mutations are linked to neurological and muscular issues, and this text discusses its impact on anesthetic management in a child.
  • A seven-year-old boy with this mutation underwent a major orthopedic surgery, experiencing challenges like being nonverbal and having visual and muscular difficulties.
  • The anesthesia approach involved using sevoflurane, a low-dose ketamine infusion, and small amounts of fentanyl while avoiding certain drugs, resulting in a smooth recovery without complications.

Article Abstract

SLC25A46 mutation is a newly recognized mitochondrial mutation causing neurological and muscular abnormalities. We describe a first-ever report of the anesthetic management of a seven-year-old boy with an SLC25A46 mutation during a major orthopedic procedure. The patient was nonverbal and presented with cerebral visual impairment, torticollis, and lower extremity contractures. Because of his new diagnosis of mitochondrial disease and history of delayed awakening after anesthesia, we performed general anesthesia with sevoflurane, a low-dose ketamine infusion, and small doses of fentanyl while avoiding propofol and maintaining normoglycemia and normothermia. No postoperative complications were noted during the recovery period.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645459PMC
http://dx.doi.org/10.7759/cureus.47076DOI Listing

Publication Analysis

Top Keywords

slc25a46 mutation
12
anesthetic management
8
mitochondrial disease
8
management child
4
child newly
4
newly identified
4
identified mitochondrial
4
disease slc25a46
4
mutation
4
mutation case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!